83
Views
14
CrossRef citations to date
0
Altmetric
Original Research

LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation

, , &
Pages 1215-1223 | Published online: 10 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhibin Jin, Heyang Li, Yinbo Long, Rong Liu & Xiaoguang Ni. (2022) MicroRNA-1269 is downregulated in glioblastoma and its maturation is regulated by long non-coding RNA SLC16A1 Antisense RNA 1. Bioengineered 13:5, pages 12749-12759.
Read now

Articles from other publishers (13)

Mehrdad Hashemi, Sophie Mousavian Roshanzamir, Sima Orouei, Pouria Daneii, Rasoul Raesi, Haleh Zokaee, Pooria Bikarannejad, Kiana Salmani, Ramin Khorrami, Mahshid Deldar Abad Paskeh, Shokooh Salimimoghadam, Mohsen Rashidi, Kiavash Hushmandi, Afshin Taheriazam & Maliheh Entezari. (2024) Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma. Non-coding RNA Research 9:2, pages 508-522.
Crossref
Yunhao Sun, Jian Sun, Kaijun Ying, Jinjin Chen, Tingting Chen, Leilei Tao, Weigang Bian & Limin Qiu. (2024) EP300 regulates the SLC16A1-AS1-AS1/TCF3 axis to promote lung cancer malignancies through the Wnt signaling pathway. Heliyon 10:6, pages e27727.
Crossref
Xian Liu, Xinyu Xiao, Xue Han, Lan Yao & Wei Lan. (2023) Natural flavonoids alleviate glioblastoma multiforme by regulating long non-coding RNA. Biomedicine & Pharmacotherapy 161, pages 114477.
Crossref
Xingjuan Zhao, Lei Fu, Liqin Zhai, Xuan Yang & Runfang Gao. (2023) MiR‐526b targets lncRNA SLC16A1‐AS1 to suppress cell proliferation in triple‐negative breast cancer. Journal of Biochemical and Molecular Toxicology 37:3.
Crossref
Tiecheng Li, Di Wang & Shuo Yang. (2022) Analysis of the subcellular location of lncRNA SLC16A1-AS1 and its interaction with premature miR-5088-5p in oral squamous cell carcinoma. Odontology 111:1, pages 41-48.
Crossref
Ni Li, Chuane Zhou & Fan Yang. (2022) lncRNA FAM230B is highly expressed in colorectal cancer and suppresses the maturation of miR-1182 to increase cell proliferation. Open Medicine 17:1, pages 1559-1567.
Crossref
Yang Liu, Mingyang Yu, Xuechao Cheng, Xingshu Zhang, Qian Luo, Sijin Liao, Zhongzheng Chen, Jianhao Zheng, Kaijun Long, Xingwei Wu, Wendong Qu, Ming Gong & Yongxiang Song. (2022) A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs. Frontiers in Genetics 13.
Crossref
Zhuo Huang, Hongbin Gao, Liangliang Qing, Biao Wang, Chaoyong He, Ning Luo, Chuncheng Lu, Shipeng Fan, Peng Gu & Hui Zhao. (2022) A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β‑catenin signaling pathway. PeerJ 10, pages e13220.
Crossref
Ayşe Ufuk, Terence Garner, Adam Stevens & Ayşe Latif. (2022) Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma. Cancers 14:5, pages 1298.
Crossref
Yan ze Li, Heng Cheng Zhu, Yang Du, Hong chao Zhao & Lei Wang. (2022) Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling. Technology in Cancer Research & Treatment 21, pages 153303382210778.
Crossref
Ke Han, Jukun Wang, Kun Qian, Teng Zhao & Yi Zhang. (2021) Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes. Bioscience Reports 41:10.
Crossref
Teng XieBin LiHuaming LiuChunwei ZhangYanhua WangZhijun ChenJunping Yan. (2021) Long non-coding RNA as a potential biomarker for prognosis of glioma. Medicine 100:33, pages e26921.
Crossref
Emel Rothzerg, Xuan Dung Ho, Jiake Xu, David Wood, Aare Märtson & Sulev Kõks. (2021) Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma. Genes 12:8, pages 1132.
Crossref